Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe / Very Severe COPD

NCT02270424 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

564

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Salmeterol / fluticasone (Seretide®)
DRUG: Bufeijianpi granule
DRUG: Bufeiyishen granule
DRUG: Yiqizishen granule
DRUG: Placebo Bufeijianpi granule
DRUG: Placebo Bufeiyishen granule
DRUG: Placebo Yiqizishen granule

Sponsor

Henan University of Traditional Chinese Medicine